Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Heise

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Virology|October 29, 2010
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirusTimothy Sheahan, Alan Whitmore, Kristin Long, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Plos Medicine|December 30, 2006
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsDamon Deming, Timothy Sheahan, Mark Heise, et al.
Plos Pathogens|January 16, 2007
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c miceAnjeanette Roberts, Damon Deming, Christopher D Paddock, et al.
Genomics Data|November 16, 2016
Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross modelRichard Green, Courtney Wilkins, Sunil Thomas, et al.
Clinical Cardiology|January 12, 2022
Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial designGerald Chi, Jane J Lee, Syed H A Kazmi, et al.
Frontiers in Immunology|August 28, 2024
Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic responseKlaus Schughart, Amber M Smith, Ephraim L Tsalik, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
Frontiers in Immunology|November 19, 2019
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus DiseaseRebecca M Broeckel, Nicole Haese, Takeshi Ando, et al.
Plos Pathogens|January 7, 2021
Novel modulators of p53-signaling encoded by unknown genes of emerging virusesDina Alzhanova, Kathleen Corcoran, Aubrey G Bailey, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Virology|October 29, 2010
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirusTimothy Sheahan, Alan Whitmore, Kristin Long, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Plos Medicine|December 30, 2006
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsDamon Deming, Timothy Sheahan, Mark Heise, et al.
Plos Pathogens|January 16, 2007
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c miceAnjeanette Roberts, Damon Deming, Christopher D Paddock, et al.
Genomics Data|November 16, 2016
Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross modelRichard Green, Courtney Wilkins, Sunil Thomas, et al.
Clinical Cardiology|January 12, 2022
Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial designGerald Chi, Jane J Lee, Syed H A Kazmi, et al.
Frontiers in Immunology|August 28, 2024
Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic responseKlaus Schughart, Amber M Smith, Ephraim L Tsalik, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
Frontiers in Immunology|November 19, 2019
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus DiseaseRebecca M Broeckel, Nicole Haese, Takeshi Ando, et al.
Plos Pathogens|January 7, 2021
Novel modulators of p53-signaling encoded by unknown genes of emerging virusesDina Alzhanova, Kathleen Corcoran, Aubrey G Bailey, et al.
Pageof 6